FBIO
Fortress Biotech Inc
2.30$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.9% | 84.1% | 64.2% | 74.5% | 78.9% | 69.0% | 79.8% | 87.4% | 78.3% | 69.9% | 62.7% | 66.7% | |
| 55.7% | 82.8% | 51.7% | 46.3% | 46.5% | 60.4% | 70.0% | 77.1% | 60.6% | 48.3% | 39.7% | 42.8% | |
| 78.1% | 82.8% | 53.7% | 53.2% | 58.9% | 60.4% | 70.0% | 77.1% | 60.6% | 48.3% | 39.7% | 42.8% | |
| 0.2% | 0.1% | 3.0% | 6.2% | 3.9% | 6.4% | 7.4% | 6.0% | 9.6% | 9.2% | 7.2% | 16.1% | |
| 0.0% | 0.0% | 0.1% | 0.1% | 0.5% | 0.4% | 0.4% | 2.5% | 4.8% | 6.1% | 10.0% | 5.2% | |
| 0.1% | 0.3% | 4.3% | 3.9% | 8.5% | 5.5% | 9.7% | 8.6% | – | – | – | – | |
| 0.0% | 0.0% | 10.9% | 7.6% | – | – | – | – | – | – | – | – | |
| 0.0% | 1.1% | 10.2% | 6.2% | 1.0% | 3.3% | 4.4% | 3.2% | 9.2% | 12.1% | 22.1% | 14.9% | |
| 21.1% | 28.9% | 51.4% | 51.0% | 86.0% | 68.0% | 40.9% | 43.0% | 83.0% | 99.1% | 101.1% | 66.5% | |
| 4.6% | 8.9% | 33.1% | 29.0% | 39.4% | 20.1% | 15.5% | 25.5% | 43.4% | 50.7% | 49.5% | 26.8% | |
| 0.2% | 0.1% | 1.2% | 5.4% | 13.5% | 4.0% | 1.9% | 1.9% | 4.3% | 3.3% | 2.3% | 1.1% | |
| 0.4% | 1.6% | 8.3% | 4.1% | 12.7% | 4.4% | 3.4% | 12.0% | 19.5% | 20.8% | 21.9% | 7.7% | |
| 15.7% | 19.5% | 15.3% | 21.7% | 42.9% | 36.4% | 17.7% | 11.7% | 31.6% | 36.3% | 40.2% | 32.1% | |
| 78.9% | 71.1% | 22.5% | 21.4% | 1.3% | 11.6% | 30.1% | 27.4% | 14.2% | 13.5% | 15.8% | 26.9% | |
| -158.7% | -160.3% | -143.6% | -126.9% | -281.1% | -192.7% | -144.8% | -138.1% | -215.5% | -414.8% | -513.7% | -395.6% | |
| 2.7% | 2.2% | 1.6% | 1.1% | 2.1% | 1.6% | 1.4% | 1.4% | 2.0% | 4.8% | 14.4% | 19.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.